ストックスクリーナーアプリを入手
82.34
0.13%
0.11
アフターアワーズ：
81.19
-1.15
-1.40%
前日終値:
$82.23
開ける：
$82.09
24時間の取引高:
5.83M
Relative Volume:
1.22
時価総額：
$255.37B
収益：
$56.53B
当期純損益:
$8.32B
株価収益率:
30.93
EPS:
2.6622
ネットキャッシュフロー:
$8.49B
1週間 パフォーマンス:
-1.27%
1か月 パフォーマンス:
+7.33%
6か月 パフォーマンス:
+14.70%
1年 パフォーマンス:
+13.06%
1日の値動き範囲:
$81.29
$82.82
1週間の範囲:
$81.29
$84.22
52週間の値動き範囲:
$61.24
$86.57
Astrazeneca PLC Stock (AZN) Company Profile
名前
Astrazeneca PLC
セクター
電話
44 20 3749 5000
住所
1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge
AZN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AZN
Astrazeneca PLC
|
82.34 | 254.96B | 56.53B | 8.32B | 8.49B | 2.6622 |
Astrazeneca PLC Stock (AZN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-27 | 再開されました | Jefferies | Buy |
| 2025-10-16 | ダウングレード | Deutsche Bank | Hold → Sell |
| 2025-04-15 | 開始されました | Exane BNP Paribas | Outperform |
| 2025-02-13 | アップグレード | UBS | Neutral → Buy |
| 2025-02-12 | 開始されました | Morgan Stanley | Overweight |
| 2024-11-20 | アップグレード | UBS | Sell → Neutral |
| 2024-11-06 | アップグレード | Deutsche Bank | Sell → Hold |
| 2024-09-13 | ダウングレード | Deutsche Bank | Hold → Sell |
| 2024-05-30 | 開始されました | Goldman | Buy |
| 2024-04-16 | アップグレード | Deutsche Bank | Sell → Hold |
| 2024-02-08 | ダウングレード | Deutsche Bank | Hold → Sell |
| 2024-01-23 | 開始されました | Morgan Stanley | Overweight |
| 2024-01-16 | 再開されました | UBS | Sell |
| 2024-01-03 | ダウングレード | Jefferies | Buy → Hold |
| 2023-12-18 | 開始されました | HSBC Securities | Buy |
| 2023-09-25 | アップグレード | Jefferies | Hold → Buy |
| 2023-07-14 | 開始されました | HSBC Securities | Buy |
| 2023-07-12 | アップグレード | UBS | Neutral → Buy |
| 2023-07-05 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2023-04-11 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2023-01-05 | 開始されました | BMO Capital Markets | Outperform |
| 2022-09-15 | ダウングレード | Credit Suisse | Outperform → Neutral |
| 2022-09-07 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-29 | アップグレード | Argus | Hold → Buy |
| 2022-06-14 | ダウングレード | UBS | Buy → Neutral |
| 2022-02-11 | アップグレード | DZ Bank | Sell → Hold |
| 2021-12-07 | ダウングレード | Jefferies | Buy → Hold |
| 2021-08-12 | 再開されました | JP Morgan | Overweight |
| 2021-04-12 | ダウングレード | Argus | Buy → Hold |
| 2021-03-16 | アップグレード | Jefferies | Hold → Buy |
| 2021-02-25 | アップグレード | UBS | Neutral → Buy |
| 2021-01-15 | 開始されました | Deutsche Bank | Buy |
| 2020-12-07 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2020-11-30 | アップグレード | UBS | Sell → Neutral |
| 2020-11-11 | アップグレード | HSBC Securities | Reduce → Hold |
| 2020-09-29 | 開始されました | Berenberg | Buy |
| 2019-11-22 | 開始されました | SVB Leerink | Outperform |
| 2019-10-25 | アップグレード | Liberum | Hold → Buy |
| 2019-04-02 | ダウングレード | UBS | Neutral → Sell |
| 2019-02-05 | 開始されました | Exane BNP Paribas | Outperform |
| 2019-01-25 | アップグレード | Shore Capital | Hold → Buy |
| 2018-12-11 | 再開されました | Jefferies | Hold |
| 2018-10-09 | 開始されました | Guggenheim | Buy |
| 2018-08-16 | ダウングレード | Jefferies | Buy → Hold |
| 2018-03-19 | アップグレード | Jefferies | Hold → Buy |
| 2018-02-06 | 繰り返されました | Leerink Partners | Mkt Perform |
| 2018-02-05 | 繰り返されました | Bernstein | Outperform |
| 2018-01-18 | 繰り返されました | Leerink Partners | Mkt Perform |
| 2017-12-29 | アップグレード | JP Morgan | Neutral → Overweight |
| 2017-10-16 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2017-09-25 | アップグレード | Exane BNP Paribas | Neutral → Outperform |
| 2017-09-22 | アップグレード | Bernstein | Mkt Perform → Outperform |
すべてを表示
Astrazeneca PLC (AZN) 最新ニュース
Up 47%, Should You Buy IonQ Right Now? - The Motley Fool
Technical signs of recovery in AstraZeneca PLC Depositary ReceiptJuly 2025 Update & Consistent Profit Alerts - newser.com
Why AstraZeneca PLC (ZEG) stock stays on buy listsTrade Performance Summary & Precise Swing Trade Alerts - newser.com
How AstraZeneca PLC (ZEG) stock trades under stagflationMarket Weekly Review & Accurate Technical Buy Alerts - newser.com
FDA Streamlines Biosimilar Development; Impacts AstraZeneca (AZN) - GuruFocus
Jennison Associates LLC Has $850.26 Million Stock Position in AstraZeneca PLC $AZN - MarketBeat
Institutional scanner results for AstraZeneca PLC Depositary ReceiptJuly 2025 Action & Daily Volume Surge Signals - newser.com
Using Python tools to backtest AstraZeneca PLC Depositary Receipt strategies2025 AllTime Highs & Detailed Earnings Play Strategies - newser.com
Is AstraZeneca PLC (Common Stock) (ZEGA) stock a top pick for value investorsMarket Trend Summary & Smart Allocation Stock Tips - newser.com
Will Precidian ETFs Trust AstraZeneca PLC stock hit Wall Street targetsJuly 2025 Breakouts & Free Verified High Yield Trade Plans - newser.com
Will AstraZeneca PLC (ZEG) stock profit from AI boomDividend Hike & Risk Controlled Daily Trade Plans - newser.com
Has AstraZeneca PLC Depositary Receipt formed a bullish divergenceWeekly Stock Report & Safe Capital Growth Trade Ideas - newser.com
AstraZeneca PLC Stock Flat Wednesday, Outperforms Market - 富途牛牛
Astrazeneca Canada Health Canada granted notice of compliance for Enhertu - MarketScreener
James Investment Research Inc. Sells 5,088 Shares of AstraZeneca PLC $AZN - MarketBeat
AstraZeneca PLC Depositary Receipt stock chart pattern explainedDay Trade & Fast Momentum Entry Tips - newser.com
AstraZeneca PLC $AZN Shares Sold by Bessemer Group Inc. - MarketBeat
Why ETFs are accumulating AstraZeneca PLC (ZEG) stockJuly 2025 News Drivers & Low Drawdown Momentum Trade Ideas - newser.com
Using fundamentals and technicals on AstraZeneca PLC Depositary ReceiptChart Signals & High Accuracy Swing Trade Signals - newser.com
Astrazeneca (AZN) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance
AstraZeneca non-executive director Euan Ashley joins DexCom board - Investing.com
AstraZeneca non-executive director Euan Ashley joins DexCom board By Investing.com - Investing.com UK
AstraZeneca news: momentum mixed as RSI nears oversold, but price holds session highs - Traders Union
AstraZeneca PLC $AZN Stock Position Decreased by Envestnet Asset Management Inc. - MarketBeat
AstraZeneca receives EU approval for Koselugo in adult neurofibromatosis - Investing.com
How AstraZeneca PLC Depositary Receipt stock responds to policy changes2025 Volume Leaders & Daily Risk Controlled Trade Plans - newser.com
AstraZeneca receives EU approval for Koselugo in adult neurofibromatosis By Investing.com - Investing.com UK
AstraZeneca's Koselugo Receives EU Approval for Rare Disease Tre - GuruFocus
United States Adult Vaccine Market Research and Company Analysis Report 2025-2033 Featuring GlaxoSmithKline, AstraZeneca, Sanofi Pasteur, Pfizer, and CSL Limited - Yahoo Finance
Oppenheimer Asset Management Inc. Grows Position in AstraZeneca PLC $AZN - MarketBeat
What market sentiment indicators show for Precidian ETFs Trust AstraZeneca PLC stockEarnings Summary Report & Long-Term Growth Plans - newser.com
Cobblestone Capital Advisors LLC NY Trims Stock Holdings in AstraZeneca PLC $AZN - MarketBeat
AstraZeneca’s Koselugo approved in EU for adult neurofibromatosis - Investing.com
AstraZeneca’s Koselugo approved in EU for adult neurofibromatosis By Investing.com - Investing.com Nigeria
What makes AstraZeneca PLC (ZEG) stock appealing to growth investorsEarnings Growth Report & Community Supported Trade Ideas - Fundação Cultural do Pará
AstraZeneca's Koselugo receives EU approval - Sharecast.com
AstraZeneca's Koselugo (Selumetinib) approved in EU - MarketScreener
REGAstraZeneca PLCDirector Declaration - TradingView
Is AstraZeneca PLC Depositary Receipt meeting your algorithmic filter criteriaPortfolio Update Report & Proven Capital Preservation Methods - newser.com
Will AstraZeneca PLC (ZEG) stock test record highs in 20252025 Earnings Surprises & Proven Capital Preservation Methods - newser.com
Published on: 2025-10-27 23:22:45 - newser.com
How AstraZeneca PLC (Common Stock) (ZEGA) stock performs during market turbulenceJuly 2025 Macro Moves & Reliable Price Breakout Signals - newser.com
Can AstraZeneca PLC Depositary Receipt stock sustain revenue growthQuarterly Portfolio Summary & Free Real-Time Volume Trigger Notifications - newser.com
Risk vs reward if holding onto AstraZeneca PLC Depositary ReceiptBreakout Watch & Safe Capital Investment Plans - newser.com
Can AstraZeneca PLC Depositary Receipt stock hit analyst price targetsJuly 2025 News Drivers & Community Consensus Stock Picks - Fundação Cultural do Pará
AstraZeneca PLC (NASDAQ:AZN) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Astrazeneca PLC (AZN) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):